YOUR LENTIVIRUS
SPECIALIZED PARTNER
Lentiviral vectors for gene therapy
DEVELOPMENT AND MANUFACTURING
GMP-SOLUTIONS CDMO
Our main aim is to adapt to your own requirements from a technical and timeline perspective
TECHNOLOGY
OWN TECHNOLOGY DEVELOPMENT
Our main aim is to implement a technology development strategy focused on providing a response to the main hurdles that currently exist within the gene therapy field
LATEST NEWS
07 January 2020
The Diario Vasco echoes the new investments in VIVEbiotech
02 December 2019
VIVEbiotech participates in the conference "The Parks in the Press"
14 November 2019
VIVEbiotech participates in the Bio-Europe fair in Hamburg
CONTACT OUR EXPERTS FOR FURTHER DISCUSSION
